Xinhui Hu
Chief Tech/Sci/R&D Officer chez ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Profil
Xinhui Hu is currently the Chief Technology Officer at Asymchem Laboratories (Tianjin) Co., Ltd.
Prior to this, he held the position of Senior VP-Chemistry, Manufacturing & Controls at Everest Medicines Ltd.
Dr. Hu's former positions include Director-New Product Development at GlaxoSmithKline (China) Investment Co., Ltd.
and Senior Director, Head-Chemistry & Manufacturing at Roche R&D Center (China) Ltd.
Dr. Hu received his doctorate degree from Brown University in 2004.
Postes actifs de Xinhui Hu
| Sociétés | Poste | Début |
|---|---|---|
| ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Chief Tech/Sci/R&D Officer | 20/06/2022 |
Anciens postes connus de Xinhui Hu
| Sociétés | Poste | Fin |
|---|---|---|
| EVEREST MEDICINES LIMITED | Chief Tech/Sci/R&D Officer | 15/06/2023 |
| Roche R&D Center (China) Ltd. | Corporate Officer/Principal | 01/10/2018 |
GlaxoSmithKline (China) Investment Co., Ltd.
 GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The private company is based in Beijing, China. | Corporate Officer/Principal | 01/07/2013 |
Formation de Xinhui Hu
| Brown University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EVEREST MEDICINES LIMITED | Health Technology |
| ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GlaxoSmithKline (China) Investment Co., Ltd.
GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The private company is based in Beijing, China. | Health Technology |
| Roche R&D Center (China) Ltd. |
